Wird geladen...

Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells

BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a smal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian Pac J Cancer Prev
Hauptverfasser: Junking, Mutita, Rattanaburee, Thidarath, Panya, Aussara, Budunova, Irina, Haegeman, Guy, Yenchitsomanus, Pa-Thai
Format: Artigo
Sprache:Inglês
Veröffentlicht: West Asia Organization for Cancer Prevention 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779449/
https://ncbi.nlm.nih.gov/pubmed/32986368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.9.2673
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!